IM Cannabis Continues European Expansion, Establishes Joint Venture and Supply Agreement in Greece

IM Cannabis Expands Innovation Portfolio

IM Cannabis Expands Innovation Portfolio with Investment in Xinteza to Develop Innovative Biosynthesis Technology based on Weizmann Institute Research Toronto and Glil Yam, Israel, January 7, 2020 – IM Cannabis Corp. (the “Company” or “IMC”) (CSE:IMCC), one of the...
IM Cannabis Continues European Expansion, Establishes Joint Venture and Supply Agreement in Greece

IM Cannabis Corp. Provides Israeli Market Update

Toronto and Glil Yam, Israel, December 18, 2019 – IM Cannabis Corp. (the “Company” or “IMC”) (CSE: IMCC), one of the world’s pioneering medical cannabis companies with operations in Israel and across Europe, is providing an update on an interim order recently issued...